This is Cabozantinib. It’s a kind of kinase inhibitor used to treat Renal Cell Carcinoma and Hepatocellular Carcinoma. It’s a multi-kinase inhibitor, meaning it goes after VEGFR, MET, and a few other kinases.
You can get it in doses of 20 mg, 40 mg, or 60 mg, all as film-coated tablets. The usual dose is 60 mg, taken every day on an empty stomach. Each bottle has 30 tablets.
